PortfoliosLab logo

Avalo Therapeutics, Inc. (AVTX)

Equity · Currency in USD · Last updated Feb 4, 2023

Company Info

ISINUS05338F1084
CUSIP05338F108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$3.89
Year Range$2.96 - $11.40
EMA (50)$4.78
EMA (200)$5.95
Average Volume$11.83K
Market Capitalization$36.62M

AVTXShare Price Chart


Loading data...

AVTXPerformance

The chart shows the growth of $10,000 invested in Avalo Therapeutics, Inc. in Sep 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $810 for a total return of roughly -91.90%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%OctoberNovemberDecember2023February
-17.26%
4.28%
AVTX (Avalo Therapeutics, Inc.)
Benchmark (^GSPC)

AVTXCompare to other instruments

Search for stocks, ETFs, and funds to compare with AVTX

Avalo Therapeutics, Inc.

AVTXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-22.36%8.17%
YTD-22.82%7.73%
6M-3.95%-0.37%
1Y-64.37%-9.87%
5Y-35.94%8.42%
10Y-29.47%10.53%

AVTXMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-21.73%
202231.94%-30.11%80.72%-8.92%-7.78%

AVTXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Avalo Therapeutics, Inc. Sharpe ratio is -0.63. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.90-0.80-0.70-0.60-0.50-0.40-0.30OctoberNovemberDecember2023February
-0.63
-0.41
AVTX (Avalo Therapeutics, Inc.)
Benchmark (^GSPC)

AVTXDividend History


Avalo Therapeutics, Inc. doesn't pay dividends

AVTXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%OctoberNovemberDecember2023February
-95.51%
-13.76%
AVTX (Avalo Therapeutics, Inc.)
Benchmark (^GSPC)

AVTXWorst Drawdowns

The table below shows the maximum drawdowns of the Avalo Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Avalo Therapeutics, Inc. is 96.58%, recorded on Sep 27, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.58%Feb 28, 2019903Sep 27, 2022
-91.55%Nov 25, 2016106Apr 28, 2017215Mar 7, 2018321
-60.57%Mar 18, 201655Jun 6, 2016117Nov 18, 2016172
-46.64%Mar 8, 2018204Dec 27, 201839Feb 25, 2019243
-35.56%Nov 19, 201547Feb 1, 201630Mar 16, 201677
-5.56%Nov 17, 20151Nov 17, 20151Nov 18, 20152

AVTXVolatility Chart

Current Avalo Therapeutics, Inc. volatility is 30.05%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%OctoberNovemberDecember2023February
30.05%
16.33%
AVTX (Avalo Therapeutics, Inc.)
Benchmark (^GSPC)